Is Compliance With MDD Really No Defence In Product Liability/Negligence Claims?
This article was originally published in Clinica
What is the interplay between regulatory requirements and liability associated with alleged defects in medical devices in the EU and how is this interplay set to change? These are questions that John Leadley, Neil O'Flaherty and William Jones of the law firm of Baker & McKenzie explore here
You may also be interested in...
The national regulator is to undergo a review in 2021 as the UK begins life as a former EU member, presenting opportunities to be seized.
Policy experts predicted how the incoming Biden administration will handle health care issues at a recent Alliance for Health Policy webinar. Rachel Nuzum, VP of state and federal policy at The Commonwealth Fund, said telehealth could be a priority.
The China National Biotec Group has filed the first application in China for the broad use of a COVID-19 vaccine, days after the national regulatory agency released review guidelines for the conditional approval of such products.